BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

Induced abortion is still a major health problem in the world and the most frequently
performed intervention in obstetrics and gynecology with an estimated total of 46 million …

" The thoroughly updated Fifth Edition of this practical handbook is a current, reliable, and
readable guide to the intelligent use of today's contraceptive options. The authors provide …

Objective This guideline reviews the evidence relating to the provision of first-trimester
medical induced abortion, including patient eligibility, counselling, and consent; evidence …

Background A wide range of drugs have been studied for first trimester medical abortion.
Studies evaluating different regimens, including combination mifepristone and misoprostol …

Medical abortion regimens have become widely used, but the frequency of infection after
medical abortion is not well documented. This systematic review provides data on infectious …

OBJECTIVE: To study the efficacy, safety, and acceptability of oral immediately swallowed
and buccal misoprostol 800 mcg after mifepristone 200 mg for terminating pregnancy …

BACKGROUND: Nonsurgical abortion methods have the potential to improve access to high-
quality abortion care. Until recently, availability and utilization of mifepristone medical …

First-trimester surgical abortion is a common, safe procedure with a major complication rate
of less than 1%. Cervical dilation before suction abortion is usually accomplished using …

Objectives This open-label non-inferiority study assessed efficacy of a common outpatient
medical abortion regimen among people with pregnancies 64–70 days and 71–77 days of …